Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...

Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...